Clinical validation of the CD32b biomarker on the European market

Linda Ya-Ting Chang

Role of innate immune signaling in myelodysplastic syndromes

Leukaemia

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Brad H Pollock

Community Clinical Oncology Program Research Base

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Brain, nervous system

Pediatric oncology or childhood cancer

William E. Evans

Pharmacogenomics of Childhood Leukemia ALL

Leukaemia

Pediatric oncology or childhood cancer

Ashley Marie Pandolfi

Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Nora C Heisterkamp

Role of Sialic Acid Modification in ALL Survival and Drug Resistance

Leukaemia

Hematology and hematologic malignancies Pathology

Marina Y Konopleva

Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy

Leukaemia

Hematology and hematologic malignancies Pathology

Denis Lacombe

EORTC Headquarters

Trachea, bronchus and lung Prostate Pancreas Ovary Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies